ATP‐binding cassette transporter A1 (ABCA1) promotes arsenic tolerance in human cells by reducing cellular arsenic accumulation. (April 2014)
- Record Type:
- Journal Article
- Title:
- ATP‐binding cassette transporter A1 (ABCA1) promotes arsenic tolerance in human cells by reducing cellular arsenic accumulation. (April 2014)
- Main Title:
- ATP‐binding cassette transporter A1 (ABCA1) promotes arsenic tolerance in human cells by reducing cellular arsenic accumulation
- Authors:
- Tan, Xiaohua
Yang, Li
Xian, Lingling
Huang, Jin
Di, Chunhong
Gu, Wenyi
Guo, Shuli
Yang, Lei - Abstract:
- <abstract abstract-type="main" id="cep12219-abs-0001"> <title>Summary</title> <p> <list id="cep12219-list-0001" list-type="order"> <list-item> <p>Arsenic is a toxic element widely distributed in nature, such as water and soil. To survive this metalloid in the environment, nearly all organisms develop strategies to tolerate arsenic toxicity to some degree. Some arsenic‐resistance genes have been identified in bacteria and yeast, but for mammals, especially humans, these genes are largely unknown.</p> </list-item> <list-item> <p>The aim of the present study was to identify these genes and benefit our intervention of arsenic resistance. We first established a human arsenic‐resistant ECV‐304 (AsRE) cell line and then used suppression subtractive hybridization and microarray analysis to identify arsenic‐resistant genes in these cells. Of the significantly upregulated genes, three ATP‐binding cassette (ABC) subfamily members, namely <italic>ABCA1</italic>, <italic> ABCE1</italic> and <italic>ABCF1</italic>, were chosen for further study with RNA interference and overexpression analyses. The 3‐(4, 5‐dimethyl‐2 thiazoyl)‐2, 5‐diphenyl‐2H‐tetrazolium bromide assay was used to determine the cell survival rate and the IC<sub>50</sub>, whereas atomic fluorescence spectrophotometry was used to determine intracellular arsenic levels.</p> </list-item> <list-item> <p>We found that among the three ABC genes, only when <italic>ABCA1</italic> gene expression was silenced did cells obviously<abstract abstract-type="main" id="cep12219-abs-0001"> <title>Summary</title> <p> <list id="cep12219-list-0001" list-type="order"> <list-item> <p>Arsenic is a toxic element widely distributed in nature, such as water and soil. To survive this metalloid in the environment, nearly all organisms develop strategies to tolerate arsenic toxicity to some degree. Some arsenic‐resistance genes have been identified in bacteria and yeast, but for mammals, especially humans, these genes are largely unknown.</p> </list-item> <list-item> <p>The aim of the present study was to identify these genes and benefit our intervention of arsenic resistance. We first established a human arsenic‐resistant ECV‐304 (AsRE) cell line and then used suppression subtractive hybridization and microarray analysis to identify arsenic‐resistant genes in these cells. Of the significantly upregulated genes, three ATP‐binding cassette (ABC) subfamily members, namely <italic>ABCA1</italic>, <italic> ABCE1</italic> and <italic>ABCF1</italic>, were chosen for further study with RNA interference and overexpression analyses. The 3‐(4, 5‐dimethyl‐2 thiazoyl)‐2, 5‐diphenyl‐2H‐tetrazolium bromide assay was used to determine the cell survival rate and the IC<sub>50</sub>, whereas atomic fluorescence spectrophotometry was used to determine intracellular arsenic levels.</p> </list-item> <list-item> <p>We found that among the three ABC genes, only when <italic>ABCA1</italic> gene expression was silenced did cells obviously lose their arsenic tolerance. The arsenic accumulation in <italic>ABCA1</italic> deficiency <italic>AsRE</italic> cells was greater than that in wild type AsRE cells. Overexpression of <italic>ABCA1</italic> in HeLa cells decreased arsenic accumulation in the cells and the cells were more resistant to As(III) than control cells transfected with empty vector.</p> </list-item> <list-item> <p>These results suggest a new functional role for <italic>ABCA1</italic> in the development of arsenic resistance in human cells.</p> </list-item> </list> </p> </abstract> … (more)
- Is Part Of:
- Clinical and experimental pharmacology and physiology. Volume 41:Number 4(2014:Apr.)
- Journal:
- Clinical and experimental pharmacology and physiology
- Issue:
- Volume 41:Number 4(2014:Apr.)
- Issue Display:
- Volume 41, Issue 4 (2014)
- Year:
- 2014
- Volume:
- 41
- Issue:
- 4
- Issue Sort Value:
- 2014-0041-0004-0000
- Page Start:
- 287
- Page End:
- 294
- Publication Date:
- 2014-04
- Subjects:
- Clinical pharmacology -- Periodicals
Pharmacology, Experimental -- Periodicals
Physiology, Experimental -- Periodicals
Physiology, Pathological -- Periodicals
615.1 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=cep ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/1440-1681.12219 ↗
- Languages:
- English
- ISSNs:
- 0305-1870
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.252000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4358.xml